Underreporting of perforating osteoma cutis: A call for recognition and diagnostic consistency
Journal of Cutaneous Pathology · 2023
DOI: 10.1111/cup.14537 ↗At a glance
Kommentar in Journal of Cutaneous Pathology, 2023. Written by Kennedy Sparling and 2 co-authors. Institution: University of Arizona, College of Medicine-Phoenix, Phoenix, Arizona, USA. Major MEDLINE topics: Skin Diseases, Genetic, Bone Diseases, Metabolic, Ossification, Heterotopic, Skin Neoplasms. 6 references.
Abstract (original language)
Neil Fernandes is a paid physician speaker for Castle Biosciences, Sanofi, and Regeneron. Other authors declare no conflict of interest. Data sharing is not applicable to this article as no new data were created or analyzed in this study.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- University of Arizona, College of Medicine-Phoenix, Phoenix, Arizona, USA.
- Phoenix Children's Hospital, Phoenix, Arizona, USA.
- Skin and Cancer Center of Arizona, Arizona, USA.
ORCID profiles: Kennedy Sparling
Cite
APA
Sparling, K., Schafernak, K. T., & Fernandes, N. (2023). Underreporting of perforating osteoma cutis: A call for recognition and diagnostic consistency. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14537
Vancouver
Sparling K, Schafernak KT, Fernandes N. Underreporting of perforating osteoma cutis: A call for recognition and diagnostic consistency. Journal of Cutaneous Pathology. 2023. doi:10.1111/cup.14537
BibTeX
@article{Sparling2023,
author = {Sparling, Kennedy and Schafernak, Kristian T and Fernandes, Neil},
title = {Underreporting of perforating osteoma cutis: A call for recognition and diagnostic consistency},
journal = {Journal of Cutaneous Pathology},
year = {2023},
doi = {10.1111/cup.14537}
}
EUVIMED